Inventor
Kevin Klopfer
Inventor
Flemington, NJ, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds25%
A61KPreparations for medical, dental or toiletry purposes21%
C07BGeneral methods of organic chemistry16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07CAcyclic or carbocyclic compounds8%
C07HSugars8%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
10,835,522Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof202010,376,503Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof201910,052,323Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use20189,974,786Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- 20189,974,780Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof20189,968,627Solid forms comprising 4-amino-1-b-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof20189,808,450'Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof'20179,795,603'Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use'20179,718,824'Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof'20179,695,146'Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof'20179,604,939'Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use'20179,403,829'Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use'20169,085,551'Solid forms of 3-(4-nitro-1-oxisoindolin-2-yl)piperidine-2,6-dione'20158,207,221'Crystalline polymorphs of a CXC-chemokine receptor ligand'20127,521,452'Preparation of pharmaceutical salts of piperazine compounds'20097,192,962'Xanthine phosphodiesterase V inhibitor polymorphs'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2012Patents assigned to SCHERING CORP (3)· patent assignee history
2007–2020Based in Flemington, NJ, US· patent location history
2012Patents assigned to DWYER MICHAEL P (1)· patent assignee history
2012Patents assigned to FU XIAOYONG (1)· patent assignee history
2015–2020Patents assigned to CELGENE CORP (7)· patent assignee history
2016–2018Patents assigned to SIGNAL PHARM LLC (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 7 | 2015–2020 |
| SIGNAL PHARM LLC | 6 | 2016–2018 |
| SCHERING CORP | 3 | 2007–2012 |
| DWYER MICHAEL P | 1 | 2012 |
| FU XIAOYONG | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Flemington, New Jersey, US | 16 | 2007–2020 |